Related Experiment Video
Updated: Jul 5, 2025

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment
Published on: January 12, 2024
Multidisciplinary atopic dermatitis program: A novel approach to managing difficult-to-control atopic dermatitis
Alexis Tracy1, Lauren Loop2, Safiyyah Bhatti1
1Division of Allergy and Immunology, Division of Pediatric Dermatology, Departments of Dermatology and Pediatrics, University of California, San Diego, and Rady Children's Hospital, San Diego, California, USA.
A multidisciplinary program significantly improved pediatric atopic dermatitis (AD) severity and patient-reported outcomes. This team-based approach enhances care for children with difficult-to-control eczema.
Area of Science:
- Pediatric Dermatology
- Clinical Pharmacy
- Allergy & Immunology
Background:
- Pediatric atopic dermatitis (AD) management can be challenging with single-specialty care.
- Disjointed communication in single-specialty approaches may hinder disease improvement.
Purpose of the Study:
- To evaluate the effectiveness of a Multidisciplinary Atopic Dermatitis Program (MADP) for pediatric AD.
- To assess improvements in disease severity and patient-reported outcomes.
Main Methods:
- The MADP involved collaborative, team-based evaluations by dermatology, allergy & immunology, and clinical pharmacy specialists.
- Comprehensive patient education and shared decision-making were integral to the program.
- Objective severity measures and patient-reported outcomes were collected.
Main Results:
- Significant improvements in AD severity were observed by the first follow-up visit.
- Body surface area (BSA) decreased by up to 56%, and pruritus, CLDQI, and POEM scores significantly reduced.
- 72.73% of patients achieved EASI 50 and 47.73% achieved EASI 75.
Conclusions:
- A multidisciplinary approach is effective for treating difficult-to-control pediatric atopic dermatitis.
- The MADP demonstrated success through improved clinician and patient-reported outcomes.
Related Concept Videos
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Asthma-IV: Nursing Management
First, in...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Chronic Pancreatitis II: Collaborative Care
Assessment:
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...

